S&P 500$7,553.68
-0.74%
2m
DOW 30$50,687.07
-1.21%
2m
NASDAQ 100$30,571.24
-0.29%
2m
Russell 2000$287.67
-1.37%
2m
Russell 1000$411.83
-0.71%
2m
S&P 400$3,751.11
-0.10%
2m
S&P 600$1,681.95
-0.85%
2m

BIODESIX (BDSX)

NASDAQ

$15.43-$0.67 (-4.14%)

Price as of Jun 03, 2026 7:56 PM EDT

$169.0M
Market Cap
171.78%
1-Year Change
Diagnostics & Research
Industry

Annual

Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022
Income Statement
Total Operating Revenue	88.5M +24.08%	71.3M +45.30%	49.1M +28.46%	38.2M -29.89%
Cost of Revenue	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Gross Profit	88.5M +24.08%	71.3M +45.30%	49.1M +28.46%	38.2M -29.89%
Sales and Marketing Expense	87.5M +8.82%	80.5M +19.39%	67.4M +9.64%	61.5M +21.67%
Research and Development Expense	-12.0M +25.55%	-9.6M -4.30%	-10.0M -23.77%	-13.1M +2.45%
Depreciation and Amortization Expense	5.7M -1.78%	5.8M +73.47%	3.3M -7.48%	3.6M +13.18%
Total Operating Expenses	116.4M +9.97%	105.8M +17.02%	90.4M +1.84%	88.8M -6.96%
Operating Profit	-27.9M -19.20%	-34.5M -16.55%	-41.3M -18.28%	-50.6M +23.56%
Interest Income	604,000 +727.40%	73,000 +1,116.67%	6,000 -94.50%	109,000 +1,111.11%
Interest Expense	-7.7M -6.56%	-8.3M -13.40%	-9.5M +18.14%	-8.1M +79.06%
Interest Income and Expense and Net	-7.1M -13.11%	-8.2M -14.11%	-9.5M +19.68%	-8.0M +76.99%
Total Nonoperating Income and Expense	-7.4M -12.34%	-8.4M -21.95%	-10.8M -27.29%	-14.9M +569.67%
Income before Taxes	-27.9M -19.20%	-34.5M -16.55%	-41.3M -18.28%	-50.6M +23.56%
Income Taxes	0 N/A	0 N/A	0 N/A	0 N/A
Extraordinary Items	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Net Income	-35.3M -17.86%	-42.9M -17.67%	-52.1M -20.32%	-65.4M +51.64%
Net Income from Continuing Operations Applicable to Common	-35.3M -17.86%	-42.9M -17.67%	-52.1M -20.32%	-65.4M +51.64%
Basic EPS and Net Income	-4.67 +1,315.15%	-0.33 -48.44%	-0.64 -58.71%	-1.55 -1.90%
Diluted EPS and Net Income	-4.67 +1,315.15%	-0.33 -48.44%	-0.64 -58.71%	-1.55 -1.90%
Basic Weighted Average Shares	7.6M -94.18%	129.7M +57.92%	82.1M +95.03%	42.1M +53.86%
Diluted Weighted Average Shares	7.6M -94.18%	129.7M +57.92%	82.1M +95.03%	42.1M +53.86%
Balance Sheet
Cash and Cash Equivalents	19.0M -27.65%	26.2M -0.15%	26.3M -39.00%	43.1M +31.72%
Short-Term Investments	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash and Cash Equivalents and Short-Term Investments	19.0M -27.65%	26.2M -0.15%	26.3M -39.00%	43.1M +31.72%
Total Current Assets	32.5M -17.64%	39.5M -0.50%	39.7M -25.60%	53.3M +22.29%
Accumulated Depreciation	12.5M +37.03%	9.1M +62.76%	5.6M -20.03%	7.0M +3.99%
Property and Plant and Equipment and Net	24.8M -10.82%	27.8M -0.14%	27.9M +376.52%	5.8M +39.94%
Total Long-Term Assets	55.0M -4.85%	57.8M -2.78%	59.4M +50.14%	39.6M +21.82%
Total Assets	87.5M -10.04%	97.2M -1.87%	99.1M +6.66%	92.9M +22.09%
Income Taxes Payable	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Total Short-Term Debt	6,000 -71.43%	21,000 -58.82%	51,000 +4.08%	49,000 +157.89%
Total Current Liabilities	17.4M +21.79%	14.3M -57.16%	33.4M +46.31%	22.8M -21.14%
Total Long-Term Debt	47.4M +30.31%	36.4M +3.36%	35.2M +40.88%	25.0M +150.22%
Total Long-Term Liabilities	72.5M +16.85%	62.1M +1.56%	61.1M +23.53%	49.5M +80.45%
Total Liabilities	89.9M +17.77%	76.4M -19.20%	94.5M +30.73%	72.3M +28.26%
Retained Earnings	-497.8M +7.62%	-462.5M +10.23%	-419.6M +14.19%	-367.4M +21.67%
Total Stockholders Equity	-2.5M -111.81%	20.9M +355.81%	4.6M -77.77%	20.6M +4.46%
Total Shares Outstanding	8.3M -94.33%	145.5M +51.18%	96.2M +23.99%	77.6M +152.08%
Cash Flow
Cash from Operating Activities	-23.3M -52.17%	-48.6M +112.72%	-22.9M -49.15%	-45.0M +59.35%
Capital Expenditures	259,000 -91.98%	3.2M -85.91%	22.9M +594.94%	3.3M +47.17%
Cash from Investing Activities	-403,000 -88.28%	-3.4M -85.08%	-23.1M +552.57%	-3.5M +38.75%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	16.4M -68.46%	52.0M +78.69%	29.1M -50.53%	58.9M +4,565.77%
Financials Ratio
Gross Margin	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Operating Margin	-31.50% -34.88%	-48.37% -42.57%	-84.22% -36.38%	-132.39% +76.25%
Return on Assets	-38.18% -12.69%	-43.73% -19.49%	-54.32% -29.87%	-77.45% +76.91%
Return on Equity	-383.09% +13.58%	-337.30% -18.54%	-414.09% +27.59%	-324.53% +128.94%
Revenue Growth	24.08% -46.84%	45.30% +59.17%	28.46% +195.20%	-29.89% -252.18%
Current Ratio	1.87 -32.37%	2.76 +132.24%	1.19 -49.15%	2.34 +55.06%
Cash Ratio	1.09 -40.59%	1.83 +133.04%	0.79 -58.31%	1.89 +67.01%
Debt-to-Equity Ratio	-19.25 -1,203.15%	1.75 -77.34%	7.70 +533.51%	1.22 +139.57%
Debt-to-Assets Ratio	0.54 +44.79%	0.37 +5.22%	0.36 +32.00%	0.27 +104.94%

Earnings & Revenue History

Debt-to-Assets

Cash Flow